Comparative Trial of the Effects of Irbesartan vs Atenolol on the Endothelial Function of Hypertensive Patients With Metabolic Syndrome

Trial Profile

Comparative Trial of the Effects of Irbesartan vs Atenolol on the Endothelial Function of Hypertensive Patients With Metabolic Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jan 2011

At a glance

  • Drugs Atenolol; Irbesartan
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 11 Jan 2011 Actual end date (Jan 2005 ) added as reported by ClinicalTrials.gov.
    • 02 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top